Global Accelerator-based BNCT System Market Growth (Status and Outlook) 2024-2030

Recently, progress in technology for accelerator-based neutron sources has increased attention regarding boron neutron capture therapy (BNCT).

BNCT is a type of radiotherapy that combines neutrons and boron drugs and is expected to be used in the treatment of refractory and recurrent cancers.

Owing to the need for high-intensity neutrons in treatment, compact accelerator-based neutron sources applicable to BNCT are being developed worldwide.

These current projects utilize cyclotrons, linear accelerators, and electrostatic accelerators as accelerators for BNCT devices.

Beryllium and lithium are the main target materials for neutron generation.

The accelerators for BNCT devices are required to accelerate charged particles with an average current ranging from a few milliamperes to a few tens of milliamperes in order to generate neutrons of sufficient intensity for the treatment.

Moreover, the target systems require technologies and mechanisms that can withstand the large heat load produced by high-power beam irradiation and prevent blistering.

The global Accelerator-based BNCT System market size is projected to grow from US$ 170.2 million in 2023 to US$ 3326.4 million in 2030; it is expected to grow at a CAGR of 52.9% from 2024 to 2030.

ReportPrime's newest research report, the “Accelerator-based BNCT System Industry Forecast,” looks at past sales and reviews total world Accelerator-based BNCT System sales in 2023, providing a comprehensive analysis by region and market sector of projected Accelerator-based BNCT System sales for 2024 through 2030.

This Insight Report provides a comprehensive analysis of the global Accelerator-based BNCT System landscape and highlights key trends related to product segmentation, company formation, revenue, market share, latest development, and M&A activity.

This report also analyzes the strategies of leading global companies with a focus on Accelerator-based BNCT System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Accelerator-based BNCT System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Accelerator-based BNCT System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Accelerator-based BNCT System.

United States market for Accelerator-based BNCT System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Accelerator-based BNCT System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Accelerator-based BNCT System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Accelerator-based BNCT System players cover:

• Neutron Therapeutics
• Sumitomo Heavy Industries
• International Particle Therapy Inc (IPT)
• RaySearch
• Neuboron Medtech
• TAE Life Sciences
• Stella Pharma

This report presents a comprehensive overview, market shares, and growth opportunities of Accelerator-based BNCT System market by product type, application, key players and key regions and countries.